News

Filter

Current filters:

Impax LaboratoriesPfizer

GSK returns IPX066 rights to Impax; Merck & Co and Pfizer link up on diabetes drug

30-04-2013

US biotech firm Impax Laboratories (Nasdaq: IPXL) saw its shares fall 2% to $17.32 in premarket trading,…

BiotechnologyDiabetesertugliflozinGlaxoSmithKlineImpax LaboratoriesIPX066LicensingMerck & CoNeurologicalPfizerPharmaceuticalResearch

Impax now to co-promote Pfizer’s Lyrica; updates on APEX-PD trial; Pfizer in deal with Stemgent on reagents

16-04-2010

Impax Pharmaceuticals, the brand products division of Impax Laboratories, has amended its 2008 co-promotion…

Impax LaboratoriesLicensingLyricaNeurologicalPfizerPharmaceuticalPristiqResearch

COMPANY SPOTLIGHT

Menarini

Back to top